Predictors of survival in patients with softtissuesurgicalmargininvolvement at radicalcystectomy
Ann Surg Oncol. 2013;20(3): 1027-34; Xylinas E, Rink M, Novara G, Green DA, Clozel T, Fritsche HM, Guillonneau B, Lotan Y, Kassouf W, Tilki D, Babjuk M, Karakiewicz PI, Montorsi F, Abdennabi J, Trinh QD, Svatek RS, Scherr DS, Zerbib M, Shariat SF
Obesity is associated with worseoncologicaloutcomes in patientstreated with radicalcystectomy
BJU Int. 2013;111(2): 249-55; Chromecki TF, Cha EK, Fajkovic H, Rink M, Ehdaie B, Svatek RS, Karakiewicz PI, Lotan Y, Tilki D, Bastian PJ, Daneshmand S, Kassouf W, Durand M, Novara G, Fritsche HM, Burger M, Izawa JI, Brisuda A, Babjuk M, Pummer K, Shariat SF
Fourteen-year oncological and functional outcomes of high-intensity focused ultrasound in localized prostate cancer
BJU Int. 2013;112(3): 322-9; Ganzer R, Fritsche HM, Brandtner A, Bründl J, Koch D, Wieland WF, Blana A
Predictors of survival in patients with disease recurrence after radical nephroureterectomy
BJU Int. 2013; Kluth LA, Xylinas E, Kent M, Hagiwara M, Kikuchi E, Matsumoto K, Ikeda M, Dalpiaz O, Zigeuner R, Aziz A, Fritsche HM, Deliere A, Raman JD, Bensalah K, Al-Matar B, Gakis G, Novara G, Klatte T, Remzi M, Comploj E, Pycha A, Rouprêt M, Tagawa ST, Chun FK, Scherr DS, Vickers A, Shariat SF
Ki-67, mini-chromosome maintenance 2 protein (MCM2) and geminin have no independent prognostic relevance for cancer-specific survival in surgically treated squamous cell carcinoma of the penis
BJU Int. 2013;112(4): E383-90; May M, Burger M, Otto W, Hakenberg OW, Wieland WF, May D, Hofstädter F, Götz S, Niessl N, Fritsche HM, Birnkammer K, Gilfrich C, Peter J, Jain A, Koch S, Lebentrau S, Riedmiller H, Rössler W, Denzinger S, Brookman-May S, Gunia S
Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy
BJU Int. 2013;111(1): 74-84; Rink M, Hansen J, Cha EK, Green DA, Babjuk M, Svatek RS, Xylinas E, Tagawa ST, Faison T, Novara G, Karakiewicz PI, Daneshmand S, Lotan Y, Kassouf W, Fritsche HM, Pycha A, Comploj E, Tilki D, Bastian PJ, Chun FK, Dahlem R, Scherr DS, Shariat SF
Predictors of cancer-specific mortality after disease recurrence following radical cystectomy
BJU Int. 2013;111(3b): E30-E36; Rink M, Lee DJ, Kent M, Xylinas E, Fritsche HM, Babjuk M, Brisuda A, Hansen J, Green DA, Aziz A, Cha EK, Novara G, Chun FK, Lotan Y, Bastian PJ, Tilki D, Gontero P, Pycha A, Baniel J, Mano R, Ficarra V, Trinh QD, Tagawa ST, Karakiewicz PI, Scherr DS, Sjoberg DD, Shariat SF, for the Bladder Cancer Research Consortium
Isolated bladder exstrophy associated with a de novo 0.9 Mb microduplication on chromosome 19p13.12
Birth Defects Res A Clin Mol Teratol. 2013;97(3): 133-9; Draaken M, Mughal SS, Pennimpede T, Wolter S, Wittler L, Ebert AK, Rösch W, Stein R, Bartels E, Schmidt D, Boemers TM, Schmiedeke E, Hoffmann P, Moebus S, Herrmann BG, Nöthen MM, Reutter H, Ludwig M
Epigenetic inactivation of ITIH5 promotes bladder cancer progression and predicts early relapse of pT1 high-grade urothelial tumours
Carcinogenesis. 2013; Rose M, Gaisa NT, Antony P, Fiedler D, Heidenreich A, Otto W, Denzinger S, Bertz S, Hartmann A, Karl A, Knüchel R, Dahl E
EORTC Progression Score Identifies Patients at High Risk of Cancer-Specific Mortality After Radical Cystectomy for Secondary Muscle-Invasive Bladder Cancer
Clin Genitourin Cancer. 2013; May M, Burger M, Brookman-May S, Stief CG, Fritsche HM, Roigas J, Zacharias M, Bader M, Mandel P, Gilfrich C, Seitz M, Tilki D
Introduction and first clinical application of a simplified immunohistochemical validation system confirms prognostic impact of KI-67 and CK20 for stage T1 urothelial bladder carcinoma: single-center analysis of eight biomarkers in a series of three hundred six patients
Clin Genitourin Cancer. 2013; Dec;11(4):537-44; Otto W, Denzinger S, Fritsche HM, Burger M, Rößler W, Bertz S, May M, Hartmann A, Hofstädter F, Wieland WF, Eder F
Value of fluorescence cystoscopy in high risk non-muscle invasive bladder cancer
Curr Urol Rep. 2013;14(2): 90-3; Mayr R, Burger M
Prediction of outcome in patients with urothelial carcinoma of the bladder following radical cystectomy using artificial neural networks
Eur J Surg Oncol. 2013;39(4): 372-9; Buchner A, May M, Burger M, Bolenz C, Herrmann E, Fritsche HM, Ellinger J, Höfner T, Nuhn P, Gratzke C, Brookman-May S, Melchior S, Peter J, Moritz R, Tilki D, Gilfrich C, Roigas J, Zacharias M, Hohenfellner M, Haferkamp A, Trojan L, Wieland WF, Müller SC, Stief CG, Bastian PJ
Prediction of 90-day Mortality After Radical Cystectomy for Bladder Cancer in a Prospective European Multicenter Cohort
Eur Urol. 2013; Aziz A, May M, Burger M, Palisaar RJ, Trinh QD, Fritsche HM, Rink M, Chun F, Martini T, Bolenz C, Mayr R, Pycha A, Nuhn P, Stief C, Novotny V, Wirth M, Seitz C, Noldus J, Gilfrich C, Shariat SF, Brookman-May S, Bastian PJ, Denzinger S, Gierth M, Roghmann F, PROMETRICS 2011 research group
Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database
Eur Urol. 2013;64(3): 472-7; Brookman-May S, May M, Shariat SF, Xylinas E, Stief C, Zigeuner R, Chromecki T, Burger M, Wieland WF, Cindolo L, Schips L, De Cobelli O, Rocco B, De Nunzio C, Feciche B, Truss M, Gilfrich C, Pahernik S, Hohenfellner M, Zastrow S, Wirth MP, Novara G, Carini M, Minervini A, Simeone C, Antonelli A, Mirone V, Longo N, Simonato A, Carmignani G, Ficarra V, members of the CORONA project and the SATURN project
Computerized Quantification and Planimetry of Prostatic Capsular Nerves in Relation to Adjacent Prostate Cancer Foci
Eur Urol. 2013; Bründl J, Schneider S, Weber F, Zeman F, Wieland WF, Ganzer R
ICUD-EAU International Consultation on Bladder Cancer 2012: Non-muscle-invasive urothelial carcinoma of the bladder
Eur Urol. 2013;63(1): 36-44; Burger M, Oosterlinck W, Konety B, Chang S, Gudjonsson S, Pruthi R, Soloway M, Solsona E, Sved P, Babjuk M, Brausi MA, Cheng C, Comperat E, Dinney C, Otto W, Shah J, Thürof J, Witjes JA
Prognostic value of perinodal lymphovascular invasion following radical cystectomy for lymph node-positive urothelial carcinoma
Eur Urol. 2013;63(4): 739-44; Fritsche HM, May M, Denzinger S, Otto W, Siegert S, Giedl C, Giedl J, Eder F, Agaimy A, Novotny V, Wirth M, Stief C, Brookman-May S, Hofstädter F, Gierth M, Aziz A, Kocot A, Riedmiller H, Bastian PJ, Toma M, Wieland WF, Hartmann A, Burger M
Reply to Michael Froehner, Rainer Koch and Manfred P. Wirth's letter to the editor re: Roman Mayr, Matthias May, Thomas Martini, et al. Comorbidity and performance indices as predictors of cancer-independent mortality but not of cancer-specific mortality after radical cystectomy for urothelial carcinoma of the bladder. Eur Urol 2012;62:662-70
Eur Urol. 2013;63(1): e10; Mayr R, May M, Fritsche HM
Pathologic nodal staging score for bladder cancer: a decision tool for adjuvant therapy after radical cystectomy
Eur Urol. 2013;63(2): 371-8; Shariat SF, Rink M, Ehdaie B, Xylinas E, Babjuk M, Merseburger AS, Svatek RS, Cha EK, Tagawa ST, Fajkovic H, Novara G, Karakiewicz PI, Trinh QD, Daneshmand S, Lotan Y, Kassouf W, Fritsche HM, Chun FK, Sonpavde G, Joual A, Scherr DS, Gonen M
Lymphadenectomy for bladder cancer at the time of radical cystectomy
Eur Urol. 2013;64(2): 266-76; Tilki D, Brausi M, Colombo R, Evans CP, Fradet Y, Fritsche HM, Lerner SP, Sagalowsky A, Shariat SF, Bochner BH
Prediction of Intravesical Recurrence After Radical Nephroureterectomy: Development of a Clinical Decision-making Tool
Eur Urol. 2013; Xylinas E, Kluth L, Passonni N, Trinh QD, Rieken M, Lee RK, Fajkovic H, Novara G, Margulis V, Raman JD, Lotan Y, Rouprêt M, Aziz A, Fritsche HM, Weizer A, Martinez-Salamanca JI, Matsumoto K, Seitz C, Remzi M, Walton T, Karakiewicz PI, Montorsi F, Zerbib M, Scherr DS, Shariat SF, for the UTUC Collaboration
The proto-oncogene ERG is a target of microRNA miR-145 in prostate cancer
FEBS J. 2013;280(9): 2105-16; Hart M, Wach S, Nolte E, Szczyrba J, Menon R, Taubert H, Hartmann A, Stoehr R, Wieland W, Grässer FA, Wullich B
Protein gene product 9.5 is diagnostically helpful in delineating high-grade renal cell cancer involving the renal medullary/sinus region from invasive urothelial cell carcinoma of the renal pelvis
Hum Pathol. 2013;44(5): 712-7; Gunia S, Erbersdobler A, Koch S, Otto W, Stabiano S, D Alterio C, Brookman-May S
Identification of ZNF217, hnRNP-K, VEGF-A and IPO7 as targets for microRNAs that are downregulated in prostate carcinoma
Int J Cancer. 2013;132(4): 775-84; Szczyrba J, Nolte E, Hart M, Döll C, Wach S, Taubert H, Keck B, Kremmer E, Stöhr R, Hartmann A, Wieland W, Wullich B, Grässer FA
Characterization and risk stratification of prostate cancer in patients undergoing radical cystoprostatectomy
Int J Urol. 2013;20(9): 866-71; Buse S, Höfner T, Müller SC, Hermann E, Wieland WF, May M, Stief CG, Bastian PJ, Hohenfellner M, Haferkamp A
Editorial Comment to Obese patients undergoing cystectomy: A population-based, propensity score matched analysis
Int J Urol. 2013; Gierth M, Burger M
Impact of clinical and histopathological parameters on disease specific survival in patients with collecting duct renal cell carcinoma: development of a disease specific risk model
J Urol. 2013;190(2): 458-63; May M, Ficarra V, Shariat SF, Zigeuner R, Chromecki T, Cindolo L, Burger M, Gunia S, Feciche B, Wenzl V, Aziz A, Chun F, Becker A, Pahernik S, Simeone C, Longo N, Zucchi A, Antonelli A, Mirone V, Stief C, Novara G, Brookman-May S, CORONA and SATURN projects , Young Academic Urologists Renal Cancer Group
Histone methylation defines an epigenetic entity in penile squamous cell carcinoma
J Urol. 2013;189(3): 1117-22; Rogenhofer S, Miersch H, Göke F, Kahl P, Wieland WF, Hofstädter F, Kristiansen G, von Ruecker A, Müller SC, Ellinger J
Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis
J Urol. 2013;189(5): 1662-9; Rouprêt M, Hupertan V, Seisen T, Colin P, Xylinas E, Yates DR, Fajkovic H, Lotan Y, Raman JD, Zigeuner R, Remzi M, Bolenz C, Novara G, Kassouf W, Ouzzane A, Rozet F, Cussenot O, Martinez-Salamanca JI, Fritsche HM, Walton TJ, Wood CG, Bensalah K, Karakiewicz PI, Montorsi F, Margulis V, Shariat SF, French National Database on Upper Tract Tumors , Upper Tract Urothelial Carcinoma Collaboration
Persistent histological changes in the exstrophic bladder after primary closure-a cause for concern?
J Urol. 2013;189(2): 671-7; Rubenwolf PC, Eder F, Ebert AK, Hofstaedter F, Woodhouse CR, Roesch WH
Assisted reproductive techniques and risk of exstrophy-epispadias complex: a German case-control study
J Urol. 2013;189(4): 1524-9; Zwink N, Jenetzky E, Hirsch K, Reifferscheid P, Schmiedeke E, Schmidt D, Reckin S, Obermayr F, Boemers TM, Stein R, Reutter H, Rösch WH, Brenner H, Ebert AK
What is to be done in a case of weak urine flow?
MMW Fortschr Med. 2013;155(11): 47; Brummeisl W
Bladder cancer: Progress in defining progression in NMIBC
Nat Rev Urol. 2013;10(12): 684-5; Gierth M, Burger M
Oncological outcome of primary versus secondary muscle-invasive bladder cancer is comparable after radical cystectomy
Urol Int. 2013;91(1): 97-102; Aziz A, Gierth M, Fritsche HM, May M, Otto W, Denzinger S, Wieland WF, Merseburger A, Riedmiller H, Kocot A, Burger M
Inherent grading characteristics of individual pathologists contribute to clinically and prognostically relevant interobserver discordance concerning Broders' grading of penile squamous cell carcinomas
Urol Int. 2013;90(2): 207-13; Gunia S, Burger M, Hakenberg OW, May D, Koch S, Jain A, Birnkammer K, Wieland WF, Otto W, Hofstädter F, Fritsche HM, Denzinger S, Gilfrich C, Brookman-May S, May M
Critical analysis and validation of lymph node density as prognostic variable in urothelial carcinoma of bladder
Urol Oncol. 2013;31(4): 480-6; Kassouf W, Svatek RS, Shariat SF, Novara G, Lerner SP, Fradet Y, Bastian PJ, Aprikian A, Karakiewicz PI, Fritsche HM, Dinney CP, Tilki D, Kamat AM, Izawa JI, Ficarra V, Lotan Y, Sagalowsky AI, Schoenberg MP, Skinner EC
Focal prostate cancer therapy: capabilities, limitations and prospects
Urologe A. 2013;52(4): 549-56; Baumunk D, Blana A, Ganzer R, Henkel T, Köllermann J, Roosen A, Machtens S, Salomon G, Sentker L, Witzsch U, Köhrmann KU, Schostak M, Arbeitsgruppe für Fokale und Mikrotherapie
Urinary bladder function disorders in childhood
Urologe A. 2013;52(1): 15-6, 18-20; Geyer VC, Ebert AK, Rösch WH
Intrascrotal lipoblastoma in childhood: diagnostic strategies and therapy planning
Urologe A. 2013;52(12): 1708-11; Promm M, Reingruber B, Rösch WH
Male circumcision is not associated with an increased prevalence of erectile dysfunction: results of the Cottbus 10,000-men survey
Urologe A. 2013;52(4): 562-9; Hoschke B, Fenske S, Brookman-May S, Spivak I, Gilfrich C, Fritsche HM, Wolff I, May M
Postoperative prognosis of chromophobic renal cell carcinoma : Comparative analysis of the multinational CORONA database
Urologe A. 2013; May M, Zigeuner R, Aziz A, Cindolo L, Gilfrich C, Schips L, De Cobelli O, Rocco B, De Nunzio C, Tubaro A, Coman I, Feciche B, Truss M, Hoschke B, Dalpiaz O, Stoltze A, Fenske F, Fritsche HM, Chromecki T, Lebentrau S, Figenshau RS, Madison K, Sánchez-Chapado M, Del Carmen Santiago Martin M, Salzano L, Lotrecchiano G, Joniau S, Waidelich R, Stief CG, Brookman-May S, Mitglieder des ,,CORONA projects" und/oder der Projektgruppe ,,Young Academic Urologists Renal Cancer Group" der European Association of Urology (EAU)
Delayed-onset ureteral obstruction after endoscopic dextranomer/hyaluronic acid copolymer (Deflux) injection for treatment of vesicoureteral reflux in children: a case series
Urology. 2013;81(3): 659-62; Rubenwolf PC, Ebert AK, Ruemmele P, Rösch WH
Disease-free survival as a surrogate for overall survival in upper tract urothelial carcinoma
World J Urol. 2013;31(1): 5-11; Fajkovic H, Cha EK, Xylinas E, Rink M, Pycha A, Seitz C, Bolenz C, Dunning A, Novara G, Trinh QD, Karakiewicz PI, Margulis V, Raman JD, Walton TJ, Baba S, Carballido J, Otto W, Montorsi F, Lotan Y, Kassouf W, Fritsche HM, Bensalah K, Zigeuner R, Scherr DS, Sonpavde G, Roupret M, Shariat SF
Clinical and pathological nodal staging score for urothelial carcinoma of the bladder: an external validation
World J Urol. 2013; Gierth M, Fritsche HM, Buchner H, May M, Aziz A, Otto W, Bolenz C, Trojan L, Hermann E, Tiemann A, Müller SC, Ellinger J, Brookman-May S, Stief CG, Tilki D, Nuhn P, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Wieland WF, Riedmiller H, Denzinger S, Bastian PJ, Burger M
Gender differences in clinicopathological features and survival in surgically treated patients with renal cell carcinoma: an analysis of the multicenter CORONA database
World J Urol. 2013; May M, Aziz A, Zigeuner R, Chromecki T, Cindolo L, Schips L, De Cobelli O, Rocco B, De Nunzio C, Tubaro A, Coman I, Truss M, Dalpiaz O, Hoschke B, Gilfrich C, Feciche B, Stoltze A, Fenske F, Fritsche HM, Figenshau RS, Madison K, Sánchez-Chapado M, Martin MD, Salzano L, Lotrecchiano G, Joniau S, Waidelich R, Stief C, Brookman-May S, Members of the CORONA project the Young Academic Urologists Renal Cancer Group
Prospective evaluation of intra-observer variability of the hydronephrosis index in sonographic examination of 44 patients with acute renal colic
World J Urol. 2013; Rud O, Horstmann M, Aziz A, Fritsche HM, Brookman-May S, Gilfrich C, Burger M, May M
The Post-Ureteroscopic Lesion Scale (PULS): a multicenter video-based evaluation of inter-rater reliability
World J Urol. 2013; Schoenthaler M, Buchholz N, Farin E, Ather H, Bach C, Bach T, Denstedt JD, Fritsche HM, Grasso M, Hakenberg OW, Herwig R, Knoll T, Kuehhas FE, Liatsikos E, Liske P, Marberger M, Osther PJ, Santos JM, Sarica K, Seitz C, Straub M, Traxer O, Trinchieri A, Turney B, Miernik A
Predictors of survival in patients with soft tissue surgical margin involvement at radical cystectomy
Ann Surg Oncol. 2013 Mar;20(3):1027-34; Xylinas E, Rink M, Novara G, Green DA, Clozel T, Fritsche HM, Guillonneau B, Lotan Y, Kassouf W, Tilki D, Babjuk M, Karakiewicz PI, Montorsi F, Abdennabi J, Trinh QD, Svatek RS, Scherr DS, Zerbib M, Shariat SF
Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy
BJU Int. 2013 Feb;111(2):249-55; Chromecki TF, Cha EK, Fajkovic H, Rink M, Ehdaie B, Svatek RS, Karakiewicz PI, Lotan Y, Tilki D, Bastian PJ, Daneshmand S, Kassouf W, Durand M, Novara G, Fritsche HM, Burger M, Izawa JI, Brisuda A, Babjuk M, Pummer K, Shariat SF
Predictors of cancer-specific mortality after disease recurrence following radical cystectomy
BJU Int. 2013 Mar;111(3b); Rink M, Lee DJ, Kent M, Xylinas E, Fritsche HM, Babjuk M, Brisuda A, Hansen J, Green DA, Aziz A, Cha EK, Novara G, Chun FK, Lotan Y, Bastian PJ, Tilki D, Gontero P, Pycha A, Baniel J, Mano R, Ficarra V, Trinh QD, Tagawa ST, Karakiewicz PI, Scherr DS, Sjoberg DD, Shariat SF, for the Bladder Cancer Research Consortium
Kontakt
Terminvereinbarung und
Befundanforderungen:
E-Mail uro-ambulanz@csj.de
Telefon 0941 782-3511
Fax 0941 782-3545
Sekretariat:
E-Mail urologie@csj.de
Telefon 0941 782-3510
Fax 0941 782-3515
